Icon

FELBATOL (nda020189)- (600MG/5ML)

FELBAMATE MYLAN SPECIALITY LP
600MG/5ML
No No
2009-Sep-26 Expired
None None
None No
Felbatol® is not indicated as a first line antiepileptic treatment (see Warnings). Felbatol® is recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use.
3 0 3
Total Other Developers None
Drugs with Suitability No
600MG/5ML ** ** - - 2
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ****** ***************, *** *********** *** ******** ***** ** **** *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** **** **** ************** ********** ***. *********** ** ******* ******, ***** ***, *******, ****** (***) ***
****** ******** ****** ******** ****** *** *********** ** **** *****, **** *******, *** ****** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.